SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-22-041399
Filing Date
2022-11-14
Accepted
2022-11-14 16:32:50
Documents
84
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10043851_10q.htm   iXBRL 10-Q 2019825
2 EXHIBIT 10.3 brhc10043851_ex10-3.htm EX-10.3 562983
3 EXHIBIT 31.1 brhc10043851_ex31-1.htm EX-31.1 6656
4 EXHIBIT 31.2 brhc10043851_ex31-2.htm EX-31.2 6664
5 EXHIBIT 32.1 brhc10043851_ex32-1.htm EX-32.1 3969
6 EXHIBIT 32.2 brhc10043851_ex32-2.htm EX-32.2 3980
12 image00001.jpg GRAPHIC 2588
13 img001_v1.jpg GRAPHIC 4428
14 img002_v1.jpg GRAPHIC 3130
  Complete submission text file 0001140361-22-041399.txt   9855463

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA erna-20220930.xsd EX-101.SCH 82249
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE erna-20220930_cal.xml EX-101.CAL 63822
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE erna-20220930_def.xml EX-101.DEF 409062
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE erna-20220930_lab.xml EX-101.LAB 965796
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE erna-20220930_pre.xml EX-101.PRE 571863
78 EXTRACTED XBRL INSTANCE DOCUMENT brhc10043851_10q_htm.xml XML 1385896
Mailing Address 10355 SCIENCE CENTER DRIVE SUITE 150 SAN DIEGO CA 92121
Business Address 10355 SCIENCE CENTER DRIVE SUITE 150 SAN DIEGO CA 92121 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-11460 | Film No.: 221386473
SIC: 2834 Pharmaceutical Preparations